
Groww BSE Hospitals ETF FOF Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
Updated: 17 Sept 2026 • 3:14 pm
Posted by:

Groww BSE Hospitals ETF FOF Direct Growth Plan is trading at ₹10.6631 as of 16 September 2026, with scheme AUM of ₹38 Cr. Its 1-year, 3-year and 5-year returns are 0%, 0% and 0%, and the fund sits in the High Risk bucket. Our view is that this is a narrow, sector-linked allocation with very limited live performance history, so it is best assessed as a high-volatility thematic exposure rather than a core diversified equity holding.
The absence of any long track record and the benchmark comparison point to a product where recent moves matter more than historical compounding. The low AUM and a portfolio built around a single underlying holding make the fund highly specific in what it owns, which can work for investors seeking a targeted hospitals theme but will not suit those looking for broad market behaviour.
Quick facts
| Particular | Details |
|---|---|
| NAV | ₹10.6631 as of 16 Sep 2026 |
| AUM | ₹38 Cr |
| Expense Ratio | 0.0% |
| Launch Date | 05 Mar 2026 |
| Min SIP | ₹500 |
| Risk Category | High Risk |
| Benchmark | Nifty 50 |
| Fund Category | Equity |
| Exit Load | No exit load |
| Fund Managers | Nikhil Satam, Aakash Chauhan, Shashi Kumar |
The fund is managed by Nikhil Satam, Aakash Chauhan and Shashi Kumar.
Source data date: as of 16 Sep 2026
Performance
| Period | Fund return | Benchmark return |
|---|---|---|
| 1M | -2.88% | -4.41% |
| 3M | -0.94% | -3.6% |
| 1Y | 0% | Data not available |
| 3Y | 0% | Data not available |
| 5Y | 0% | Data not available |
The recent picture is mixed but not alarming versus the benchmark. Over 1 month, the fund fell less than Nifty 50, and over 3 months it again held up better than the index. That suggests the portfolio has recently been less weak than the market reference even though both have moved lower. The short history, however, makes it difficult to judge how the fund behaves across a full market cycle.
Because the scheme launched on 05 Mar 2026, the 1-year, 3-year and 5-year figures are not yet meaningful as rolling compounding records. The reported 0% readings therefore reflect the absence of a live long-term track record rather than a mature history of flat returns. For investors, that means the fund should be read as an early-stage thematic vehicle, not as a proven compounding engine.
The 1-month and 3-month paths show some day-to-day fluctuation, but they do not indicate severe instability over the periods shown. Even so, the High Risk label remains important because the strategy is tied to a focused hospitals exposure rather than broad diversification. In our view, the main question is not whether the fund has beaten the benchmark in a very short window, but whether an investor wants that concentrated sector exposure at all.
Source data date: as of 16 Sep 2026
Should you BUY or HOLD Groww BSE Hospitals ETF FOF?
A fund's past returns alone don't tell you whether you should buy it today or continue holding it.
The right decision depends on factors such as your current allocation, purchase price, risk profile, investment horizon and the role this fund plays in your overall portfolio.
Already holding Groww BSE Hospitals ETF FOF? Thinking of investing now?
Peer comparison
| Fund | 1Y return | 3Y return | 5Y return |
|---|---|---|---|
| Groww BSE Hospitals ETF FOF Direct Growth Plan | 0% | 0% | 0% |
| Axis Gold and Silver Passive FoF Direct Growth Plan | Data not available | Data not available | Data not available |
| HSBC Gold ETF FOF Direct Growth Plan | Data not available | Data not available | Data not available |
| Bandhan Silver ETF FOF Direct Growth Plan | Data not available | Data not available | Data not available |
| The Wealth Company Gold ETF FOF Direct Growth Plan | Data not available | Data not available | Data not available |
| Mirae Asset BSE Midcap 150 Momentum 30 ETF FOF Direct Growth Plan | Data not available | Data not available | Data not available |
This assessment is prepared by Uniapps Investment Adviser Pvt. Ltd. under SEBI Registered Investment Adviser registration INA000017639.
On the only comparable short-window figures available, the fund has been less weak than Nifty 50 in both the 1-month and 3-month periods. That is a useful sign, but it is still a very short read on the strategy. The peer set does not provide usable long-horizon return figures here, so the cleaner conclusion is that current short-term behaviour looks steadier than the benchmark while the longer-term comparison cannot yet be meaningfully built from live history.
That split matters because a young thematic fund can look calm in a brief window and still remain high risk in portfolio terms. In our view, the available peer data supports only a narrow conclusion: the fund has not shown a worse short-term drift than the benchmark, but there is not enough live history to claim durable outperformance over peers on a 3-year or 5-year basis.
Source data date: as of 16 Sep 2026
Want to know more? Log in to Univest for more mutual fund insights.
Portfolio: where your money goes
| Holding | Sector | Weight |
|---|---|---|
| Groww BSE Hospitals ETF | Domestic Mutual Funds Units | 100.06% |
The portfolio is extremely concentrated in one disclosed holding, which is likely to have greater influence on returns than a multi-holding structure would. At a weight of 100.06%, the single position dominates the scheme’s visible asset mix, so the fund’s behaviour will largely reflect the underlying ETF rather than any broad stock-picking spread.
Because only one holding is disclosed, there is no drop-off from the largest position to a tenth holding to analyse. That in itself is informative: the scheme is not built as a diversified basket of many line items, but as a one-layer fund-of-fund structure. For investors, that may reduce complexity, but it also means the strategy depends heavily on the performance path of the underlying hospitals ETF.
With one disclosed holding out of one total holding, the concentration is complete in the visible portfolio. That makes the theme clear and easy to understand, but it also means diversification benefit inside the fund is limited. Investors who want the hospitals theme may appreciate the simplicity; investors who want multiple sources of return may find the structure too narrow.
Source data date: as of 16 Sep 2026
Who should invest
This fund fits investors who are comfortable with High Risk and who want a specific hospitals-sector exposure rather than a broad equity portfolio. The short live history and the 0% longer-horizon figures mean it is better suited to someone who can tolerate uncertainty and is willing to hold through periods when the theme may lag the wider market.
A longer horizon is important because the available performance window is still very limited. The main trade-off is between thematic focus and diversification: the single-holding structure makes the strategy easy to understand, but it also means outcomes will be closely tied to the underlying hospitals ETF. Investors who prefer steadier, market-wide participation may find that balance too narrow.
Tax and exit load
| Holding period | Tax rate | Description |
|---|---|---|
| Units held less than 1 year | 20% | Short-term capital gains tax |
| Units held more than 1 year | 12.5% | Long-term capital gains tax |
Exit load: No exit load.
Source data date: as of 16 Sep 2026
Frequently asked questions
What is the current NAV of Groww BSE Hospitals ETF FOF Direct Growth Plan?
The current NAV is ₹10.6631 as of 16 September 2026.
What are the fund’s 1-year, 3-year and 5-year returns?
Its 1-year, 3-year and 5-year returns are 0%, 0% and 0%.
How has the fund done against Nifty 50 recently?
It has been less weak than Nifty 50 over both 1 month and 3 months. The fund returned -2.88% over 1 month versus -4.41% for the benchmark, and -0.94% over 3 months versus -3.6% for the benchmark.
How does it compare with the listed peer funds on available return data?
The peer list does not provide usable 1-year, 3-year or 5-year return figures for comparison. On the short-window figures shown, the fund has held up better than Nifty 50, but the peer long-horizon comparison is not available.
What is the minimum SIP amount?
The minimum SIP amount is ₹500.
What is the fund’s risk profile and exit load?
It is classified as High Risk, and it has no exit load. The portfolio is also highly concentrated in one disclosed holding, so the theme will closely follow the underlying hospitals ETF.
Bottom line
Groww BSE Hospitals ETF FOF Direct Growth Plan looks like a newly launched, narrowly focused thematic fund rather than a mature all-weather equity option. Recent short-term behaviour has been less weak than Nifty 50, but the live long-term return record is not yet established. Compared with the listed peers, the available data does not give a meaningful longer-horizon edge story. The single-holding structure keeps the theme clear, but it also leaves the fund highly dependent on one underlying exposure.
Published on 17 September 2026 at 3:12 PM IST
Explore mutual funds with Univest
Review mutual fund data, compare performance and explore fund insights on Univest.
RIA disclosure
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully before investing. This review is prepared by Uniapps Investment Adviser Pvt. Ltd. (earlier known as Uniapps Global Research Pvt. Ltd.) under SEBI Registered Investment Adviser registration INA000017639 for general informational purposes and is not personalized investment advice.
Recent Articles

SBI Quality Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
17 September 2026

UTI Nifty Midcap 150 Quality 50 Index Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
17 September 2026

DSP Multi Asset Omni FoF Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
17 September 2026

ICICI Pru Housing Opp Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
17 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
SBI Quality Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
UTI Nifty Midcap 150 Quality 50 Index Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
DSP Multi Asset Omni FoF Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
ICICI Pru Housing Opp Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
Groww Nifty PSE ETF FOF Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
Popular this week
Nippon India Nifty AAA CPSE Bond Plus SDL - Apr 2027 Maturity 60:40 Index Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





